NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/06/2025
Voltar para busca
Dado oficial do USPTO
VIROQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
13/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
04/02/2021
Data de registro
02/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/05/2023
Última transação
13/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
GORAN, BRADLEY
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BAG Diagnostics GmbH
Representantes
Andrew Dorisio Dickinson Wright PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscience and photography; chemicals used in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; compositions for fire extinguishing and prevention; tempering and soldering preparations; adhesives for use in industry; compostmanuresfertilizers; biological preparations for use in industry and science; biological tissueblood serums for use in scientific and medical research; enzymes for industrial use; primers for diagnostic of viral and bacterial diseases for scientific and research use; nucleotides for scientific and research use; reagents for scientific or medical research useenzyme immunoassays for detecting relevant microorganismstoxinsGMO (genetically modified organisms) and allergens in foodstuffs; products for sterilisation and disinfection controlreagents for testing the sterility of medical equipment; diagnostic preparations for medical and scientific use; chemical test kits for molecular biological deficiencies for laboratory or research use; products for conducting molecular genetic servicesgenetic identity tests comprised of reagents for non-medical purposes
Classe 5
Pharmaceuticalsmedical and veterinary preparations for the diagnosis of viral and bacterial diseases; dietetic food and beverages adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; plasters and gauze specifically adapted for use for medical dressings; material for stopping teethdental wax; herbicides; vermin destroying preparations; enzymes for medical purposes; primers for the diagnosis of viral and bacterial diseases for medical purposes; medicated preparations in the nature of nucleotides used for diagnostic of viral and bacterial diseases; medical diagnostic test media in liquid and powder form featuring immunofluorescence tests for detecting antibodies; medical diagnostic test media in liquid and powder form for measuring human proteinsmedicated anti-serums for identifying human proteins for the diagnosis of viral and bacterial diseases; diagnostic kits comprised of medical diagnostic reagents and assays for quick testing of bodily fluids and proteins for use in detection of viral and bacterial diseases; diagnostic agentspreparations and substances for medical purposes; genetic identity molecular biological tests comprised of reagents for medical purposes; products for conducting molecular genetic proceduresreagents for use in medical genetic testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
27/08/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2023
FIMP
FINAL DISPOSITION PROCESSED
07/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/05/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
23/03/2023
CHPB
POST PUBLICATION AMENDMENT - ENTERED
26/01/2023
APET
ASSIGNED TO PETITION STAFF
24/01/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
23/01/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/01/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/09/2022
PUBO
PUBLISHED FOR OPPOSITION
13/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/09/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/07/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/04/2022
GNFR
FINAL REFUSAL E-MAILED
21/04/2022
CNFR
FINAL REFUSAL WRITTEN
21/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/03/2022
RFNT
REFUSAL PROCESSED BY IB
25/10/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/10/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/09/2021
RFRR
REFUSAL PROCESSED BY MPU
09/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/08/2021
CNRT
NON-FINAL ACTION WRITTEN
27/08/2021
DOCK
ASSIGNED TO EXAMINER
27/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIROQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.